Hepatitis A vaccine study for cirrhosis patients
Part of Digestive system clinical trials.
This study tests how well a single dose of the hepatitis A vaccine works in people with cirrhosis who have no prior immunity. It aims to see if the vaccine provides protection for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have cirrhosis.
- You have not already had the hepatitis A vaccine.
- You do not have antibodies against hepatitis A (meaning you are not already immune).
- You are not pregnant.
- You are medically stable enough to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at infections in people with cirrhosis caused by hepatitis B or C. It aims to find which germs cause these infections, so doctors can choose better treatments.
This study looks at the nutrition and dietary needs of people with cirrhosis (a type of long-term liver damage). It aims to understand how nutrition affects their health, so doctors can give better advice.
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
This study compares giving the hepatitis B vaccine in 2 doses versus 3 doses for people with cirrhosis who do not yet have protection against hepatitis B. It may help your care team choose the schedule most likely to build lasting immunity.
This study tests a vaccine strategy for people who are being evaluated and waiting for a liver transplant. The goal is to see how well the immune system responds and how the results are interpreted before transplant.
This trial tests a new protein-based vaccine to prevent hepatitis C. It is for healthy, non-smoking adults aged 18-45 who are up to date on their flu and COVID-19 vaccines.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.